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Nuclei contain two differentially regulated pools of diacylglycerol
Clive S. D’Santos*, Jonathan H. Clarke*, Robin F. Irvine† and Nullin Divecha*
A number of recent studies have highlighted the
presence of a nuclear pool of inositol lipids [1,2] that is
regulated during progression through the cell cycle
[1,3], differentiation [1,2] and after DNA damage [2],
suggesting that a number of different regulatory
pathways impinge upon this pool of lipids. It has been
suggested that the downstream consequence of the
activation of one of these nuclear phosphoinositide (PI)
regulatory pathways is the generation of nuclear
diacylglycerol (DAG) [1,3,4], which is important in the
activation of nuclear protein kinase C (PKC) [5–7].
Activation of PKC in turn appears to regulate the
progression of cells through G1 and into S phase [4]
and through G2 to mitosis [3,8–11]. Although the
evidence is enticing, there is as yet no direct
demonstration that nuclear PIs can be hydrolysed to
generate nuclear DAG. Previous data in murine
erythroleukemia (MEL) cells have suggested that
nuclear phosphoinositidase Cβ1 (PIC-β1) activity is
important in the generation of nuclear DAG. Here, we
demonstrate that the molecular species of nuclear DAG
bears little resemblance to the PI pool and is unlikely to
be generated directly by hydrolysis of these inositol
lipids. Further, we show that there are in fact two
distinct subnuclear pools of DAG; one that is highly
disaturated and mono-unsaturated (representing more
than 90% of the total nuclear DAG) and one that is
highly polyunsaturated and is likely to be derived from
the hydrolysis of PI. Analysis of these pools, either after
differentiation or during cell-cycle progression,
suggests that the pools are independently regulated,
possibly by the regulation of two different nuclear
phospholipase Cs (PLCs).
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Results and discussion
We have identified the molecular species of DAG, PI,
phosphatidylcholine (PC) and phosphatidic acid (PA)
present in the nuclei of MEL cells. Nuclear PI or PC was
hydrolysed with specific phospholipases and the DAG
generated was phosphorylated to form PA, using a non-
specific DAG kinase, in the presence of 32P-labelled ATP.
This PA was then dimethylated and separated using
argentation chromatography, which distinguishes different
molecular species primarily on the basis of the number of
double bonds that they contain. The DAG derived from
nuclear PI was predominantly unsaturated, with over 70%
of the total species containing two, four and five double
bonds, whereas that derived from nuclear PC was predom-
inantly mono-unsaturated and disaturated (Figure 1a).
This pattern of saturation acts as a ‘fingerprint’, indicating
from which precursor lipid the nuclear DAG is derived.
Subsequent analysis of nuclear DAG showed that over
90% of the total species were disaturated or mono-unsatu-
rated, showing that it cannot be derived solely from the
hydrolysis of PI lipids, but is likely to be derived from a
balance of de novo synthesis, hydrolysis of precursor lipids
such as PC or PI, and the removal of DAG. We have also
found this pattern of DAG in the nuclei of Swiss 3T3 cells
and porcine endothelial cells (data not shown).
As previous data suggested that incubation of intact nuclei
at 30°C generates DAG derived from the hydrolysis of PI
[3], we analysed DAG generation using argentation chro-
matography. A nuclear activity was able to generate DAG,
but subsequent analysis revealed that this DAG species
was highly mono-unsaturated. There was a decrease in the
disaturated DAG that might have been due to a DAG
lipase activity or to a desaturase activity; a desaturase
activity could not, however, account for the increase in the
other unsaturated lipids alone (a decrease of 50 with a
comparable increase in the total DAGs of 1150 arbitrary
values; Figure 1b, D609). This reaction was not inhibited
by D609, (an inhibitor of PC-specific PLC [12]),
alkyllysophospholipids (ALP), U73122 (a PIC-specific
inhibitor [13]) or butanol (Figure 1b). Indeed, in intact
cells, butanol treatment did not lead to either the accumu-
lation of nuclear phosphatidylbutanol (PB) or a decrease in
nuclear DAG, suggesting that if a phospholipase D (PLD)
activity was present, butanol was unable to act as a substi-
tute for water in the transphosphatidylation reaction. No
such activity was present in non-nuclear membranes.
These data are consistent with the presence of a pool of
nuclear DAG that is not derived from PI but may be
derived from the hydrolysis of PC.
The above data did not show whether DAG could be
derived from PI hydrolysis. Previously, it was demon-
strated that PA can be generated in intact isolated nuclei in
the presence of ATP, through the phosphorylation of the
endogenous DAG by an endogenous nuclear DAG kinase
[1,2]. Argentation analysis of this PA showed that it was
highly polyunsaturated (Figure 2a, lane 1). This could
occur if the nuclear DAG kinase has a specificity for
polyunsaturated DAG or if this specific DAG is co-
compartmentalised with the nuclear DAG kinase. Addition
of exogenous DAG showed that the enzyme had no speci-
ficity even when the various species were added together
and the products separated after the reaction (Figure 2a,
lane 2). Moreover, disruption of the nuclei using deoxy-
cholate and subsequent labelling of endogenous PA pro-
duced a species profile that was similar to the nuclear DAG
profile previously described (Figure 2a, lane 3).
Neither inhibitors of PLD nor inhibitors of PC–PLC had
any effect on the in vitro labeling of PA (Figure 2b). Two
structurally different PIC inhibitors, U73122 and ALP,
however, completely inhibited the production of nuclear
PA (Figure 2b), whereas the inactive analogue, U73343,
had no effect (data not shown). These data demonstrate
that there are two distinct pools of DAG in the nucleus,
one of which is highly mono-unsaturated and disaturated
and is not accessible to the nuclear DAG kinase. The
second pool is highly polyunsaturated and the data are
consistent with this being produced by a nuclear PIC,
which, importantly, is able to utilise endogenous nuclear
PIs. This second pool of DAG is then utilised directly by a
co-compartmentalised DAG kinase to generate PA. These
data also demonstrate that the production of labelled
polyunsaturated PA in intact nuclei is a direct measure of
the nuclear PIC activity using endogenous substrates.
The nuclear DAG levels in MEL cells during progression
through the cell cycle or after differentiation were studied
to establish whether these pools of DAG are indepen-
dently regulated. Differentiation of these cells along the
erythroid pathway leads to a decrease in the levels of
nuclear DAG, suggested to occur through the downregula-
tion of nuclear PIC-β1 activity [1,2]. The data in Figure 3a,
however, show that the decrease in nuclear DAG occurs
predominantly through a decrease in the disaturated and
the mono-unsaturated DAG (as these are the predominant
species in control nuclei), showing that an inhibition of
nuclear PIC activity cannot be the direct reason for this
decrease (Figure 3a). Although we and others [1,2] have
shown that nuclear PIC-β1 is downregulated after differ-
entiation, and that when assayed with exogenous substrate
the total nuclear PIC activity decreases, we found that,
when assayed using intact nuclei and endogenous PI, the
nuclear PIC activity remained unchanged (Figure 3b).
Analysis of the generation of nuclear DAG in intact nuclei
showed that this activity was decreased by 50% after dif-
ferentiation (Figure 3c). 
We then characterised changes in the nuclear DAG as a
consequence of progression through the cell cycle. Nuclei
were isolated at various time points after release from a
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(a) Analysis of nuclear DAG species. Nuclei were purified from MEL
cells as described and a total lipid extract was isolated. The DAG was
removed by chromatography on a neomycin column and the bound PC
and PI were re-extracted from the column. The PC and PI were then
hydrolysed using specific phospholipases and the DAG generated was
phosphorylated to PA using a non-specific DAG kinase. The PA was
analysed using argentation chromatography to reveal the saturation
pattern of the DAG species. The data are presented as the percentage
of the total DAG ± standard error of the mean (SEM) (n = 3). (b) Intact
isolated nuclei are able to generate mono-unsaturated DAG. Nuclei
were incubated either on ice or at 30oC in the presence or absence of
the various inhibitors. Nuclear DAG was extracted and phosphorylated
to PA and analysed by argentation chromatography. The data are
presented as the change in DAG species between nuclei that were
incubated on ice and at 30°C. Data are shown ± SEM (n = 3). In (a,b)
the numbers in the inset indicate the number of double bonds.
nocodazole block and either the DAG or the PIC activity
in intact nuclei was assayed. No changes in either the
levels of nuclear DAG or in the nuclear activity that
generates mono-unsaturated and disaturated DAG were
seen as cells progressed through the cell cycle (data not
shown). In contrast to this, there was a threefold increase
in the nuclear PA labelling 2 hours after release from the
nocodazole block (Figure 4a), which was completely
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Figure 2
(a) Nuclear PA, generated by labelling of the
endogenous DAG by an endogenous DAG
kinase, is highly polyunsaturated and likely to
be derived from PIC-mediated hydrolysis of PI.
Arrows indicate the positions of DAG species
with the indicated numbers of double bonds.
Lane 1 shows the argentation separation of
labelled PA after incubation of intact nuclei with
32P-labelled ATP. Lane 2 shows the
argentation separation of labelled PA after
incubation of nuclei with exogenously added
DAG (an equimolar mixture of all four types).
Lane 3 shows the argentation separation of
nuclear PA labelled in vitro in the presence of
deoxycholate (2 mM). (b) Intact nuclei were
incubated for 2.5 min with 32P-labelled ATP
either on ice in the presence of ALP or at 30°C
in the presence or absence of various
phospholipase inhibitors. The labelled PA was
isolated and separated by argentation
chromatography. The numbers in the inset refer
to the number of double bonds in the DAG
species. The data are the means of duplicates
and the range of the values is shown. Each
experiment was carried out at least three times.
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(a) DAG was extracted from nuclei isolated
from either control cells (control) or from
DMSO-differentiated cells (DMSO), converted
to PA and separated by argentation
chromatography. The figure shows a thin-layer
chromatography (TLC) plate representative of
at least three experiments. To determine the
statistical relevance, the decrease in the
particular DAG species after differentiation was
expressed as a percentage and the SEM for
these values is as follows: no double bonds,
44.75 ± 3.4 (n = 4); 1 double bond, 53 ± 2.4
(n = 4); 2 double bonds, 36.6 ± 13.8 (n = 3)
and 4 double bonds, 36.6 ± 8.5 (n = 3). All of
these values are significantly different
(p < 0.01) from the control value. (b) Nuclei
from control cells or from differentiated cells
were incubated for 2.5 min with 32P-labelled
ATP, after which time the PA was extracted
and analysed by argentation chromatography.
The data shown are the means of triplicate
measurements from one of three independent
experiments. (c) Isolated nuclei from either
control or differentiated cells were incubated
for 15 min either on ice or at 30°C. The DAG
was extracted, phosphorylated to form PA and
subsequently analysed by argentation
chromatography. The data are represented as
the difference in nuclear DAG production
between incubation on ice or at 30°C and
represent the PC-specific PLC activity. The
data shown are the means of duplicate
samples for a single experiment. For a
statistical analysis, the percentage decrease in
the different DAG species was determined for
three separate experiments and expressed as a
percentage ± SEM as follows: 1 double bond,
42 ± 4; 2 double bonds, 45.3 ± 0.71; and 4
double bonds, 56 ± 10. All of these numbers
are significantly different (p < 0.01) from the
control values. In (b,c), the numbers in the inset
refer to the number of double bonds in the
DAG species.
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inhibited by pre-incubation with ALP (Figure 4a) or with
U73122 (data not shown). Analysis of the DNA content
showed that the cells were in G1 at this point. Species
analysis of the increase in PA over the 4.5 hour time point,
showed that more than 70% of the PA was highly polyun-
saturated (Figure 4b).
These data are consistent with the idea that nuclei contain
two separate pools of DAG that are independently regu-
lated to produce structurally distinct molecular species of
DAG. The data strongly suggest that one of these pools is
derived from the hydrolysis of PI lipids through the action
of a PIC. The other pool of DAG is derived from various
pathways, one of which may be through the action of a
nuclear PC-specific PLC, as previously suggested [14]. As
nuclear DAGs derived from various lipid precursors are
different with respect to not only their structure but also
their intranuclear localisation, this may represent a mecha-
nism for the distinct spatial and temporal activation of spe-
cific isoforms of PKC within the nucleus.
Supplementary material
Additional methodological detail is published with this paper on the
internet.
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Figure 4
(a) Nuclei were isolated from cells
progressing through the cell cycle at the
indicated times after release from nocodazole
and were incubated with 32P-labelled ATP for
2.5 min in the presence or absence of ALP
(10 µM). The PA was extracted and analysed
by TLC to determine the total incorporation of
32P. The percentage of cells in the various
phases was determined by fluorescence-
activated cell sorting (FACS) analysis. (b) The
PA extracted in (a) was analysed by
argentation chromatography to determine the
molecular species and the data shown are the
percentage difference in PA species between
the 2.5 h and the 4.5 h time point. 
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